TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Understanding the Impact of School-Based Physical Activity Programs
Brief Summary: The central hypothesis of the Fueling Learning Through Exercise (FLEX) study is two innovative school-based physical activity programs (a walking/running program and a classroom activity break program) will increase school-time and total daily minutes children engage in moderate-to-vigorous physical activity, relative to controls, and that children who attend schools with these PA programs will demonstrate improved cognitive functioning, academic achievement, and attendance, relative to controls.


Options:
A: Arm Label: Treatment Group; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity | Arm Label: Wait List Group; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Physical Activity | Intervention Type: BEHAVIORAL; Name: Physical Activity; Assigned to Arm(s): Treatment Group, Wait List Group
B: Arm Label: "PE as Usual" Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Education (PE) programme | Intervention Type: BEHAVIORAL; Name: Physical Education (PE) programme; Assigned to Arm(s): Intervention Group
C: Arm Label: "Fortaleça sua Saúde" program; Type: EXPERIMENTAL; Interventions: Behavioral: "Fortaleça sua Saúde" program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: "Fortaleça sua Saúde" program; Assigned to Arm(s): "Fortaleça sua Saúde" program
D: Arm Label: Walking/Running Program; Type: EXPERIMENTAL; Interventions: Behavioral: Walking/Running program | Arm Label: Classroom activity break program; Type: EXPERIMENTAL; Interventions: Behavioral: Classroom physical activity break program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Walking/Running program; Assigned to Arm(s): Walking/Running Program | Intervention Type: BEHAVIORAL; Name: Classroom physical activity break program; Assigned to Arm(s): Classroom activity break program

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Understanding the Impact of School-Based Physical Activity Programs
Brief Summary: The central hypothesis of the Fueling Learning Through Exercise (FLEX) study is two innovative school-based physical activity programs (a walking/running program and a classroom activity break program) will increase school-time and total daily minutes children engage in moderate-to-vigorous physical activity, relative to controls, and that children who attend schools with these PA programs will demonstrate improved cognitive functioning, academic achievement, and attendance, relative to controls.


Options:
A: Arm Label: Treatment Group; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity | Arm Label: Wait List Group; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Physical Activity | Intervention Type: BEHAVIORAL; Name: Physical Activity; Assigned to Arm(s): Treatment Group, Wait List Group
B: Arm Label: Intervention camp; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention camp | Arm Label: Small intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Small intervention | Intervention Type: BEHAVIORAL; Name: Small intervention; Assigned to Arm(s): Small intervention | Intervention Type: BEHAVIORAL; Name: Intervention camp; Assigned to Arm(s): Intervention camp
C: Arm Label: Walking/Running Program; Type: EXPERIMENTAL; Interventions: Behavioral: Walking/Running program | Arm Label: Classroom activity break program; Type: EXPERIMENTAL; Interventions: Behavioral: Classroom physical activity break program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Walking/Running program; Assigned to Arm(s): Walking/Running Program | Intervention Type: BEHAVIORAL; Name: Classroom physical activity break program; Assigned to Arm(s): Classroom activity break program
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Understanding the Impact of School-Based Physical Activity Programs
Brief Summary: The central hypothesis of the Fueling Learning Through Exercise (FLEX) study is two innovative school-based physical activity programs (a walking/running program and a classroom activity break program) will increase school-time and total daily minutes children engage in moderate-to-vigorous physical activity, relative to controls, and that children who attend schools with these PA programs will demonstrate improved cognitive functioning, academic achievement, and attendance, relative to controls.


Options:
A: Arm Label: Walking/Running Program; Type: EXPERIMENTAL; Interventions: Behavioral: Walking/Running program | Arm Label: Classroom activity break program; Type: EXPERIMENTAL; Interventions: Behavioral: Classroom physical activity break program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Walking/Running program; Assigned to Arm(s): Walking/Running Program | Intervention Type: BEHAVIORAL; Name: Classroom physical activity break program; Assigned to Arm(s): Classroom activity break program
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: A 5-months physical exercise-based program | Intervention Type: BEHAVIORAL; Name: A 5-months physical exercise-based program; Assigned to Arm(s): Intervention Group
C: Intervention Type: BEHAVIORAL; Name: diet, reducing; Assigned to Arm(s): N/A
D: Intervention Type: BEHAVIORAL; Name: Switch active lifestyles brought to you by MediaWise; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Switch active lifestyles from MediaWise; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Understanding the Impact of School-Based Physical Activity Programs
Brief Summary: The central hypothesis of the Fueling Learning Through Exercise (FLEX) study is two innovative school-based physical activity programs (a walking/running program and a classroom activity break program) will increase school-time and total daily minutes children engage in moderate-to-vigorous physical activity, relative to controls, and that children who attend schools with these PA programs will demonstrate improved cognitive functioning, academic achievement, and attendance, relative to controls.


Options:
A: Arm Label: Walking/Running Program; Type: EXPERIMENTAL; Interventions: Behavioral: Walking/Running program | Arm Label: Classroom activity break program; Type: EXPERIMENTAL; Interventions: Behavioral: Classroom physical activity break program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Walking/Running program; Assigned to Arm(s): Walking/Running Program | Intervention Type: BEHAVIORAL; Name: Classroom physical activity break program; Assigned to Arm(s): Classroom activity break program
B: Arm Label: Team Nutriathlon intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Team Nutriathlon intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Team Nutriathlon intervention; Assigned to Arm(s): Team Nutriathlon intervention
C: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Face-to-face family mentoring and education sessions, Behavioral: Telephone follow-up | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Face-to-face family mentoring and education sessions; Assigned to Arm(s): Intervention Group | Intervention Type: BEHAVIORAL; Name: Telephone follow-up; Assigned to Arm(s): Intervention Group
D: Arm Label: reducing beverages and sugar and increase physical activity; Type: EXPERIMENTAL; Interventions: Behavioral: lifestyle | Arm Label: control -no intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: lifestyle; Assigned to Arm(s): reducing beverages and sugar and increase physical activity

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Use of Interactive Binocular Treatment (I-BiT) for the Management of Anisometropic, Strabismic and Mixed Amblyopia in Children Aged 3.5 - 12 Years
Brief Summary: Around one child in fifty has a lazy eye (termed amblyopia) where the eye is structurally normal but the vision fails to develop correctly. Around half of these children also have a squint (strabismus) where each eye has a different direction of gaze. This condition is the commonest cause of visual impairment in one eye in children.

This is a randomised control trial of wearing glasses alone (which will result in some visual improvement, termed refractive adaptation) and wearing glasses combined with using I-BiT Plus.

The hypothesis is that using I-BiT Plus will result in an improved visual outcome.


Options:
A: Arm Label: I-BiT Plus; Type: EXPERIMENTAL; Interventions: Device: I-Bit plus | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: I-Bit plus; Assigned to Arm(s): I-BiT Plus
B: Intervention Type: DEVICE; Name: Eye patch; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: spectacles; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: atropine; Assigned to Arm(s): N/A
C: Arm Label: I-BiTTM game; Type: EXPERIMENTAL; Interventions: Device: I-BiTTM game | Arm Label: Non-I-BiTTM game; Type: ACTIVE_COMPARATOR; Interventions: Device: Non-I-BiTTM game | Arm Label: I-BiTTM DVD; Type: EXPERIMENTAL; Interventions: Device: I-BiTTM DVD | Intervention Type: DEVICE; Name: I-BiTTM game; Assigned to Arm(s): I-BiTTM game | Intervention Type: DEVICE; Name: Non-I-BiTTM game; Assigned to Arm(s): Non-I-BiTTM game | Intervention Type: DEVICE; Name: I-BiTTM DVD; Assigned to Arm(s): I-BiTTM DVD
D: Arm Label: Patching; Type: ACTIVE_COMPARATOR; Interventions: Device: Patching, Procedure: Near activities | Arm Label: Bangerter filters; Type: ACTIVE_COMPARATOR; Interventions: Device: Bangerter filters, Procedure: Near activities | Intervention Type: DEVICE; Name: Bangerter filters; Assigned to Arm(s): Bangerter filters | Intervention Type: DEVICE; Name: Patching; Assigned to Arm(s): Patching | Intervention Type: PROCEDURE; Name: Near activities; Assigned to Arm(s): Bangerter filters, Patching

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Advanced Renal Cell Carcinoma (CLEAR)
Brief Summary: The primary purpose of the study is to demonstrate that lenvatinib in combination with everolimus (Arm A) or pembrolizumab (Arm B) is superior compared to sunitinib alone (Arm C) in improving progression-free survival (PFS) (by independent imaging review \[IIR\] using Response Evaluation Criteria in Solid Tumors \[RECIST 1.1\]) as first-line treatment in participants with advanced renal cell carcinoma (RCC).


Options:
A: Arm Label: Axitinib; Type: EXPERIMENTAL; Interventions: Drug: Axitinib (AG-013736) | Arm Label: Sorafenib; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sorafenib | Intervention Type: DRUG; Name: Axitinib (AG-013736); Assigned to Arm(s): Axitinib | Intervention Type: DRUG; Name: Sorafenib; Assigned to Arm(s): Sorafenib
B: Arm Label: Atezolizumab + Bevacizumab; Type: EXPERIMENTAL; Interventions: Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Drug: Bevacizumab | Arm Label: Sunitinib; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sunitinib | Intervention Type: DRUG; Name: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody; Assigned to Arm(s): Atezolizumab + Bevacizumab | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Atezolizumab + Bevacizumab | Intervention Type: DRUG; Name: Sunitinib; Assigned to Arm(s): Sunitinib
C: Arm Label: Lenvatinib 18 mg plus Everolimus 5 mg; Type: EXPERIMENTAL; Interventions: Drug: Lenvatinib, Drug: Everolimus | Arm Label: Lenvatinib 20 mg plus Pembrolizumab 200 mg; Type: EXPERIMENTAL; Interventions: Drug: Lenvatinib, Drug: Pembrolizumab | Arm Label: Sunitinib 50 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sunitinib | Intervention Type: DRUG; Name: Lenvatinib; Assigned to Arm(s): Lenvatinib 18 mg plus Everolimus 5 mg, Lenvatinib 20 mg plus Pembrolizumab 200 mg | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): Lenvatinib 18 mg plus Everolimus 5 mg | Intervention Type: DRUG; Name: Pembrolizumab; Assigned to Arm(s): Lenvatinib 20 mg plus Pembrolizumab 200 mg | Intervention Type: DRUG; Name: Sunitinib; Assigned to Arm(s): Sunitinib 50 mg
D: Arm Label: Nivolumab (A); Type: EXPERIMENTAL; Interventions: Drug: Nivolumab | Arm Label: TKI (B); Type: ACTIVE_COMPARATOR; Interventions: Drug: Sunitinib, Drug: Pazopanib | Intervention Type: DRUG; Name: Nivolumab; Assigned to Arm(s): Nivolumab (A) | Intervention Type: DRUG; Name: Sunitinib; Assigned to Arm(s): TKI (B) | Intervention Type: DRUG; Name: Pazopanib; Assigned to Arm(s): TKI (B)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluate the Value of Telehomecare for Diabetes
Brief Summary: This is a mixed methods study that evaluates the effectiveness of the BlueStar app and its implementation in 3 hospital/health system sites across Ontario. The 6 month study includes 300 participants that are randomized to an immediate treatment group or a delayed intervention group. The primary outcomes include changes in HbA1c and patient reported outcomes and experience measures. Qualitative interviews with various stakeholders will explore issues relating to successful implementation.


Options:
A: Arm Label: Immediate Treatment Group; Type: EXPERIMENTAL; Interventions: Device: BlueStar app | Arm Label: Delayed Treatment Group; Type: OTHER; Interventions: Device: BlueStar app | Intervention Type: DEVICE; Name: BlueStar app; Assigned to Arm(s): Delayed Treatment Group, Immediate Treatment Group
B: Arm Label: SMS texting intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SMS texting intervention | Arm Label: Control-Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control-Usual Care | Intervention Type: BEHAVIORAL; Name: SMS texting intervention; Assigned to Arm(s): SMS texting intervention | Intervention Type: BEHAVIORAL; Name: Control-Usual Care; Assigned to Arm(s): Control-Usual Care
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Device: placebo | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: VISITS + PDA-FIT system | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Device: PDA-FIT System + telephone follow-up | Intervention Type: DEVICE; Name: placebo; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: VISITS + PDA-FIT system; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: PDA-FIT System + telephone follow-up; Assigned to Arm(s): 3
D: Arm Label: Group Clinic; Type: EXPERIMENTAL; Interventions: Behavioral: Improving outcomes using group clinics for older patients | Arm Label: Uusual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Standard of Care | Intervention Type: BEHAVIORAL; Name: Improving outcomes using group clinics for older patients; Assigned to Arm(s): Group Clinic | Intervention Type: BEHAVIORAL; Name: Standard of Care; Assigned to Arm(s): Uusual Care

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: What is the Best Sexual Intercourse Strategy for Couples Actively Trying to Conceive?
Brief Summary: This study will asses the effectiveness of two strategies for timed intercourse in couples actively trying to conceive


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Preconception advice | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Instruction in the Creighton Model Fertility Care System | Intervention Type: BEHAVIORAL; Name: Instruction in the Creighton Model Fertility Care System; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Preconception advice; Assigned to Arm(s): 1
B: Arm Label: Active; Type: N/A; Interventions: N/A | Arm Label: Control; Type: N/A; Interventions: N/A
C: Arm Label: every other day; Type: EXPERIMENTAL; Interventions: Other: health educational video | Arm Label: fertile window; Type: EXPERIMENTAL; Interventions: Other: health educational video | Arm Label: CG; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: health educational video; Assigned to Arm(s): every other day, fertile window
D: Arm Label: Electronic hormonal fertility monitoring; Type: EXPERIMENTAL; Interventions: Behavioral: Electronic hormonal fertility monitoring | Arm Label: Cervical mucus monitoring; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-monitoring | Intervention Type: BEHAVIORAL; Name: Electronic hormonal fertility monitoring; Assigned to Arm(s): Electronic hormonal fertility monitoring | Intervention Type: BEHAVIORAL; Name: Self-monitoring; Assigned to Arm(s): Cervical mucus monitoring

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Two Different Flaps Associated With Connective Tissue Graft in the Treatment of Gingival Recession: A Randomized Clinical Trial
Brief Summary: The aim of this study was to compare clinical, esthetic and patient-centered outcomes of coronally advanced tunnel (TUN) and coronally advanced flap (CAF) both associated with connective tissue graft (CTG) in the treatment of gingival recession.


Options:
A: Arm Label: CAF plus connective tissue graft; Type: ACTIVE_COMPARATOR; Interventions: Procedure: CAF plus connective tissue graft, Drug: Sodium dipyrone, Drug: chlorhexidine rinse | Arm Label: Tunnel plus connective tissue graft; Type: EXPERIMENTAL; Interventions: Procedure: Tunnel plus connective tissue graft, Drug: Sodium dipyrone, Drug: chlorhexidine rinse | Intervention Type: PROCEDURE; Name: CAF plus connective tissue graft; Assigned to Arm(s): CAF plus connective tissue graft | Intervention Type: PROCEDURE; Name: Tunnel plus connective tissue graft; Assigned to Arm(s): Tunnel plus connective tissue graft | Intervention Type: DRUG; Name: Sodium dipyrone; Assigned to Arm(s): CAF plus connective tissue graft, Tunnel plus connective tissue graft | Intervention Type: DRUG; Name: chlorhexidine rinse; Assigned to Arm(s): CAF plus connective tissue graft, Tunnel plus connective tissue graft
B: Arm Label: Mucograft + CAF; Type: EXPERIMENTAL; Interventions: Device: Mucograft | Arm Label: CAF; Type: EXPERIMENTAL; Interventions: Procedure: Coronally advanced flap (CAF) | Intervention Type: DEVICE; Name: Mucograft; Assigned to Arm(s): Mucograft + CAF | Intervention Type: PROCEDURE; Name: Coronally advanced flap (CAF); Assigned to Arm(s): CAF
C: Arm Label: Connective tissue graft (CTG); Type: SHAM_COMPARATOR; Interventions: Procedure: Connective tissue graft | Arm Label: Connective tissue graft plus laser (CTG+L); Type: EXPERIMENTAL; Interventions: Procedure: Connective tissue graft | Intervention Type: PROCEDURE; Name: Connective tissue graft; Assigned to Arm(s): Connective tissue graft (CTG), Connective tissue graft plus laser (CTG+L)
D: Arm Label: CAF+MC+EMD; Type: EXPERIMENTAL; Interventions: Device: Mucograft, Device: Emdogain, Procedure: Coronally Advanced flap | Arm Label: CAF+MC; Type: ACTIVE_COMPARATOR; Interventions: Device: Mucograft, Procedure: Coronally Advanced flap | Arm Label: CAF+EMD; Type: ACTIVE_COMPARATOR; Interventions: Device: Emdogain, Procedure: Coronally Advanced flap | Arm Label: CAF; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Coronally Advanced flap | Intervention Type: DEVICE; Name: Mucograft; Assigned to Arm(s): CAF+MC, CAF+MC+EMD | Intervention Type: DEVICE; Name: Emdogain; Assigned to Arm(s): CAF+EMD, CAF+MC+EMD | Intervention Type: PROCEDURE; Name: Coronally Advanced flap; Assigned to Arm(s): CAF, CAF+EMD, CAF+MC, CAF+MC+EMD

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Targeting Caregivers to Enhance Health Behaviors in Pediatric Cancer Survivors (NOURISH-T)
Brief Summary: This purpose of this pilot study is to investigate the feasibility of and optimal time post cancer treatment to offer caregivers a new health behavior change intervention (NOURISH-T), as well as assess its preliminary efficacy on specific child health behaviors. The study will also explore whether caregivers NOURISH-T exhibit more improvements than caregivers in EUC (standard care).


Options:
A: Arm Label: Low Energy Density, Small Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: Low Energy Density, Medium Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: Low Energy Density, Large Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Small Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Medium Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Large Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Intervention Type: OTHER; Name: Varying meal energy density and portion size; Assigned to Arm(s): High Energy Density, Large Portions, High Energy Density, Medium Portions, High Energy Density, Small Portions, Low Energy Density, Large Portions, Low Energy Density, Medium Portions, Low Energy Density, Small Portions
B: Arm Label: Level of intervention intensity; Type: EXPERIMENTAL; Interventions: Behavioral: High Intensity, Behavioral: Low Intensity | Intervention Type: BEHAVIORAL; Name: High Intensity; Assigned to Arm(s): Level of intervention intensity | Intervention Type: BEHAVIORAL; Name: Low Intensity; Assigned to Arm(s): Level of intervention intensity
C: Arm Label: NOURISH-T; Type: EXPERIMENTAL; Interventions: Behavioral: NOURISH-T | Arm Label: Enhanced Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: NOURISH-T; Assigned to Arm(s): NOURISH-T | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care
D: Arm Label: National Vaccine Program Plus Radio; Type: EXPERIMENTAL; Interventions: Behavioral: Appropriate complementary feeding messages | Arm Label: Comparison (no intervention); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Appropriate complementary feeding messages; Assigned to Arm(s): National Vaccine Program Plus Radio

Answer: C